Aimovig 140 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FD9QZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,102
Award facts
- Contract value 100% obligated
- $4,102.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,102.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIMOVIG 140 mg/ml auto-injectors, with a completion date of September 26, 2025. The award was made without a set-aside designation, indicating competitive selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order represents a child contract under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical and medical supply distribution globally.
AIMOVIG is a monoclonal antibody treatment indicated for migraine prevention and is delivered via auto-injector for patient self-administration. Through its DLA Troop Support IDC, AmerisourceBergen Drug Corp supplies a diverse portfolio of pharmaceutical products across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, and other federal healthcare systems. The firm fixed-price structure and competitive award reflect the contractor's demonstrated capability to meet federal pharmaceutical procurement standards through the DLA's established medical supply chain framework.
Quick answers
Who was awarded contract SPE2DB25FD9QZ?
SPE2DB25FD9QZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FD9QZ worth?
The government has obligated $4,102 on SPE2DB25FD9QZ.
Is contract SPE2DB25FD9QZ an order under another contract?
Yes. SPE2DB25FD9QZ is a delivery order under SPE2DB20D1051, an indefinite delivery contract.
Was contract SPE2DB25FD9QZ competed?
The extent of competition for SPE2DB25FD9QZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award